Clinical trialNCT04660760UnknownPhase 2Interventional

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

SponsorAcademic and Community Cancer Research UnitedEnrollment116Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastric Cancer AJCC v8Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8+25 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mohamad B Sonbol
Academic and Community Cancer Research United
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
Darryl A. Outlaw
Not, yet, recruiting
Mayo Clinic in Arizona
Scottsdale, Arizona, United States
Mohamad B. Sonbol
Recruiting
Arizona Clinical Research Center
Tucson, Arizona, United States
Withdrawn
Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
Syma Iqbal →
Recruiting
Mayo Clinic in Florida
Jacksonville, Florida, United States
Jason S. Starr
Recruiting
Cleveland Clinic-Weston
Weston, Florida, United States
Arun Nagarajan
Recruiting
Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
Withdrawn
Carle Cancer Center Nci Community Oncology Research Program
Urbana, Illinois, United States
Withdrawn
University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
Pashtoon M. Kasi
Not, yet, recruiting
Cancer Center of Kansas - Wichita
Wichita, Kansas, United States
Withdrawn
Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
Completed
University of Nebraska Medical Center
Omaha, Nebraska, United States
Withdrawn
Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
Michael Gibson
Recruiting
Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, United States
Anthony J. Jaslowski
Recruiting
Aurora Cancer Care-Milwaukee West
Wauwatosa, Wisconsin, United States
Withdrawn

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 16 Jun 2021
Primary completion: 31 Jul 2024
Completion: 31 May 2026
Last update posted: 1 Apr 2024
Registered enrollment: 116
Registry id: NCT04660760

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.